Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Tirzepatide Versus Semaglutide Once Weekly in Patients With Type 2 DiabetesN. Engl. J. Med 2021 Jun 25;[EPub Ahead of Print], JP Frías, MJ Davies, J Rosenstock, FC Pérez Manghi, L Fernández Landó, BK Bergman, B Liu, X Cui, K Brown
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.